Multiple sclerosis (MS) is a costly disease for society, because it affects young people and has a relentless course with progressive accumulation of physical disability and cognitive deficits. MS is expensive not only because of the high prices of available treatments, but also because of reduced employment/job retention for patients and their caregivers. This is especially true for patients with disease onset during childhood, who usually reach more severe disability at a younger age than those with adult-onset MS.
Scott Buxton
Scott is editor of Physiospot so expect to see his work popping up frequently. Away from the keyboard he is AHP Workforce Development Lead at the Royal United Hospital in Bath as well as an Advanced Practice Physio in Frailty/Geriatrics with a special interest in osteoporosis and sarcopenia.